Optical Purity of Milnacipran via Chiral Resolution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing optically pure milnacipran are complex and costly, with asymmetric synthesis and chromatography methods offering high enantiomeric excess but at the expense of operational simplicity and cost-effectiveness.
Innovation Solution
A process using racemic milnacipran and optically pure resolving agents in a solvent, followed by crystallization and acid-base reactions to achieve optically pure milnacipran with high yield and purity, suitable for industrial production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If asymmetric synthesis method or chromatography method is used, then optical purity is improved, but process complexity and cost increase
Solution Approach 1:
The patent uses a chiral resolving agent as an intermediary substance to separate enantiomers of milnacipran through diastereomeric salt formation. The resolving agent temporarily combines with the racemic mixture to create separable diastereomers, which are then separated by conventional crystallization and salt metathesis, avoiding complex asymmetric synthesis or chromatography while achieving high optical purity
Solution Approach 2:
The patent changes physical and chemical parameters such as solvent type, temperature, and pH to optimize the resolution process. By adjusting these parameters during crystallization and salt metathesis steps, the process achieves high optical purity through simple filtration and precipitation rather than complex equipment or multi-step synthesis
2Manufacturing precision
If asymmetric synthesis method or chromatography method is used, then optical purity is improved, but manufacturing cost increases
Solution Approach 1:
The patent employs conventional, inexpensive resolving agents and standard laboratory equipment for crystallization and filtration. The process uses readily available chemicals and simple operations that can be performed with basic manufacturing infrastructure, significantly reducing capital investment and operational costs compared to expensive chromatography systems or complex asymmetric synthesis catalysts
Solution Approach 2:
The patent optimizes manufacturing parameters such as solvent selection, temperature profiles, and pH conditions to maximize yield and optical purity while minimizing material consumption and energy usage. These parameter optimizations enable cost-effective production at scale without requiring advanced equipment or specialized facilities
3Manufacturing precision
If asymmetric synthesis method or chromatography method is used, then optical purity is improved, but operational simplicity decreases
Solution Approach 1:
The chiral resolving agent serves as a mediator that transforms the difficult task of enantiomer separation into a simple crystallization and filtration process. The resolving agent forms diastereomeric salts that have different solubilities, allowing separation by conventional filtration rather than requiring complex chromatography operations or specialized asymmetric synthesis techniques
Solution Approach 2:
The patent utilizes phase transitions during crystallization and precipitation steps to achieve separation. By controlling temperature and solvent conditions, the desired enantiomer crystallizes out of solution or precipitates as an insoluble salt, enabling simple filtration and isolation without complex operational steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves optical purities exceeding 99.0% with a yield of 50-65%, is cost-effective, and suitable for industrial scale production, overcoming the limitations of existing methods.
Implementation Method 1
crystallization and filtered to give the resolved product
Implementation Method 2
the optically pure resolving agents in the molar ratio of 1:0.5-1.5 are dissolved in ketone or alcohol solvent, and mixed, then crystallization is performed and filtered to give the resolved product
Implementation Method 3
alkali is added to the suspended milnacipran to separate out specially free alkali of optically pure milnacipran
Data Source
AI summary
The present invention discloses a process for preparing optically pure milnacipran and their pharmaceutically acceptable salts, which adopts racemic milnacipran as starting material, tartaric acid derivatives and their compositions as resolving agents to resolve.